
With a lawsuit, a House delay bill and drugmaker intervention motions in play, here's where HRSA's 340B rebate pilot stands ahead of Jan. 1.
Click the title above for a link to open the Pharmaceutical Commerce November 2021 issue in an interactive PDF format.
almost 5 years ago
AI’s predictive power on the big stagealmost 5 years ago
What’s Next for Med Tech?almost 5 years ago
Chatbot Potential in Clinical Researchalmost 5 years ago
The Pulse of Digital in Pharmaalmost 5 years ago
RWD Benefits at the Point of Carealmost 5 years ago
Pharma & Big Data: New Heights Beckonalmost 5 years ago
Marketing Data Hubs: When Operations and Analytics Collidealmost 5 years ago
CSA a Game Changer for the Life Sciences?almost 5 years ago
The Key Force in CGT Commercializationabout 5 years ago
Aligning Medical Information and PV





